WHO Guidelines For Herbal Drug Standard Is at Ion
WHO Guidelines For Herbal Drug Standard Is at Ion
WHO Guidelines For Herbal Drug Standard Is at Ion
Standardization
G.Sunny Grace
100809885017
M.Pharm 1/1
CONTENTS
Introduction
Standardization of
herbal drugs/products
Evaluation of herbal
drugs/products
WHO guidelines
Conclusion
References
INTRODUCTION
In recent years , there has
been great demand for
plant derived products in
developed countries.
Standardisation is used
to describe all measures,
which are taken during the
manufacturing process and
quality control leading to a
reproducible quality.
Evaluation of drug means
confirmation of its identity
and determination of its
quality and purity and
detection of its
adulteration.
Standardization of HerBAL DRUGS/PRODUCTS
Authentication
Foreign matter
Organoleptic evaluation
Tissues of diagnostic importance
present in the drug powder
Ash values and extractive values
Volatile matter
Moisture content determination
Chromatogaphic and
spectroscopic evaluation
Determination of heavy metals
Pesticide residue
Microbial contamination
Radioactive contamination
EVALUATION OF HERBAL
DRUGS/PRODUCTS
Biological parameter
1. Evaluation of adaptogenic activity profile of
herbal preparation.
2. Evaluation of antioxidant activity of herbal
products
3. Evaluation of microbial contamination reduction
on plants through technological process of
decoction and spray dry
4. Evaluation of nitric oxide scavenging activity of
selected medicinal plants used in inflammatory
diseases
5. The lipid peroxidation inhibitory activity
Contd…
Evaluation of marketed polyherbal antidiabetic
formulations using biomarker charantin
In vitro and In vivo evaluation of hair growth
potential of shoe flower
Clinical evaluation to assess the safety and
efficacy of coded herbal “Dysmo-off” Vs allopathic
medicine for treatment of primary dysmenorrhea
Thermographic Evaluation
Biochemical Evaluation
Evaluation of Kutaj-Ghanavati for alkaloidal
principles
Organoleptic evaluation
Classical evaluation
The quality of raw materials can be tested
according to following format:
Name of the drug
Part of the plant used
Area of collection
Distribution details
Season of Crop
Time and year of collection
Pesticide and insecticides
Condition of the drug
Form of the drug
Who gUidelines
Quality control of crude drugs material, plant preparations
and finished products: Botanical evaluation- sensory
characters, foreign organic matter, microscopical,
histological etc.
Stability assessment and shelf-life: Physicochemical
character of drug- Physical and chemical identity,
chromatographic fingerprints, ash values, extractive values,
moisture content, volatile oil and alkaloidal assays etc.
Safety assessment: Toxicity details- pesticide residues,
heavy metals, microbial contamination pathogens like
E.coli, Salmonella, P.aeroginosa, S.aureus, etc.
Assessment of efficacy by ethnomedical informations,
pharmacological parameters, biological activity profiles etc.
WHO GUIDELINES FOR GENERAL LIMITS
Harmful organic matter : Totally free from it
Innocuous foreign matter : Free from it
Pesticidal residues, arsenic and heavy metals :
Max residue limits = BW*ADI*Extn factor
Safety factor*100*MDI
Where ADI= Avg daily intake
BW = Body weight
MDI= Mean daily intake of drug
India can emerge as the major country and play the lead role in
production of standardized, therapeutically effective ayurvedic
formulation. India needs to explore the medicinally important
plants. This can be achieved only if the herbal products are
evaluated and analyzed using sophisticated modern techniques of
standardization such as UV-visible, TLC, HPLC, HPTLC, GC-MS,
spectrofluorimetric and other methods.
References
1.Sagar Bhanu P.S., Zafar R., Panwar R., “Herbal drug standardization”, The Indian Pharmacist, vol.
4(35), May 2005, 2005, pp.19-22.
2.Patel P.M., Patel N.M., Goyal R.K., “Evaluation of marketed polyherbal antidiabetic formulations
uses biomarker charantin”, The Pharma Review, vol.4 (22), June 2006, pp.113.
3.Patel P.M., Patel N.M., Goyal R.K., “Quality control of herbal products”, The Indian Pharmacist,
vol.5(45), March 2006, pp.26-30.
4.Bhutani K.K., “Herbal medicines an enigma and challenge to science and directions for new
initiatives”, Indian Journal of Natural Products, vol.19 (1), March 2003, pp.3-8.
5.Kokate C.K., Purohit A.P., Gokhale S.B., “Analytical pharmacognosy”, Pharmacognosy, 30th
edition, Feb. 2005, pp.1,99.
6.Shrikumar S., Maheshwari U., Sughanti A., Ravi T.K., “WHO guidelines for herbal drug
standardization”, 2006.
7.Ansari S.H., “Standardization of crude drugs”, Essentials of Pharmacognosy, Ist edition, 2005-06,
pp.14, 581.
8.Gokhale S.B., Surana S.J., “Fluorescence quenching as a tool for identification and quality control
of crude drugs”, Planta indica, vol 2 (3), July 2006, pp.47.
9.Shaw P.C., Pui-Hat Butt P., “Authentication of Panax species and their adulterants by random
primed polymerase chain reaction”, Planta Medica, vol. 61, 1995, pp.466-469.
10.Lazarowych N.J., Pekos P., “Use of fingerprinting and marker compounds for identification and
standardization of botanical drugs: Strategies for applying pharmaceutical HPLC analysis to herbal
products”, Drug Information Journal, Vol.32, 1998, pp.497-512.
QUERIES
questions
THANK YOU